Risk factors for classical Kaposi sarcoma in a population-based case-control study in sicily

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 12, 2008, Pages 3435-3443

  Anderson, Lesley A ^a,b   Lauria, Carmela ^c   Romano, Nino ^d   Brown, Elizabeth E ^e   Whitby, Denise ^f   Graubard, Barry I ^a   Li, Yan ^a   Messina, Angelo ^g   Gafà, Lorenzo ^c   Vitale, Francesco ^d   Goedert, James J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c Lega Italiana per la Lotta Contro i Tumori Sez Ragusa   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f SAIC FREDERICK INC   (United States)

^g UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; CIGARETTE SMOKING; DISEASE ASSOCIATION; FEMALE; HERPES VIRUS INFECTION; HUMAN; ITALY; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; SARCOMA, KAPOSI; SICILY; SMOKING;

EID: 57449114042     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0671     Document Type: Article

References (40)

1. Moore PS, Chang Y. Kaposi's sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology. Am J Epidemiol 1998;147:217-21.
2. Rady PL, Yen A, Martin RW III, Nedelcu I, Hughes TK, Tyring SK. Herpesvirus-like DNA sequences in classic Kaposi's sarcomas. J Med Virol 1995;47:179-83.
3. Brown EE, Fallin D, Ruczinski I, et al. Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity. Cancer Epidemiol Biomarkers Prev 2006;15:926-34.
4. Touloumi G, Hatzakis A, Potouridou I, et al. The role of immunosuppression and immune-activation in classic Kaposi's sarcoma. Int J Cancer 1999;82:817-21.
5. Whitby D, Luppi M, Sabin C, et al. Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission. Br J Cancer 2000;82:702-4.
6. Vitale F, Briffa DV, Whitby D, et al. Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. Int J Cancer 2001;91:588-91.
7. Goedert JJ, Vitale F, Lauria C, et al. Risk factors for classical Kaposi's sarcoma. J Natl Cancer Inst 2002;94:1712-8.
8. Nawar E, Mbulaiteye SM, Gallant JE, et al. Risk factors for Kaposi's sarcoma among HHV-8 seropositive homosexual men with AIDS. Int J Cancer 2005;115:296-300.
9. Hoover DR, Black C, Jacobson LP, et al. Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 1993;138:266-78.
10. Dictor M, Attewell R. Epidemiology of Kaposi's sarcoma in Sweden prior to the acquired immunodeficiency syndrome. Int J Cancer 1988;42:346-51.
11. Iscovich J, Boffetta P, Winkelmann R, Brennan P. Classic Kaposi's sarcoma as a second primary neoplasm. Int J Cancer 1999;80:178-82.
12. Safai B, Mike V, Giraldo G, Beth E, Good RA. Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications. Cancer 1980;45:1472-9.
13. Perna AM, Bonura F, Vitale F, et al. Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily. Int J Epidemiol 2000;29:175-9.
14. Little RJA, Rubin DB. Statistical analysis with missing data. New York: Wiley; 1987.
15. Guttman-Yassky E, Dubnov J, Kra-Oz Z, et al. Classic Kaposi sarcoma. Which KSHV-seropositive individuals are at risk? Cancer 2006;106:413-9.
16. Conley LJ, Bush TJ, Buchbinder SP, Penley KA, Judson FN, Holmberg SD. The association between cigarette smoking and selected HIV-related medical conditions. AIDS 1996;10:1121-6.
17. Gallus S, Pacifici R, Colombo P, et al. Prevalence of smoking and attitude towards smoking regulation in Italy, 2004. Eur J Cancer Prev 2006;15:77-81.
18. Giovino GA, Schooley MW, Zhu BP, et al. Surveillance for selected tobacco-use behaviors-United States, 1900-1994. MMWR CDC Surveill Summ 1994;43:1-43.
19. Franceschi S, Naett C. Trends in smoking in Europe. Eur J Cancer Prev 1995;4:271-84.
20. Goedert JJ, Scoppio BM, Pfeiffer R, et al. Treatment of classic Kaposi sarcoma with a nicotine dermal patch: a phase II clinical trial. J Eur Acad Dermatol Venereol 2008 [Epub ahead of print].
21. Nouri-Shirazi M, Tinajero R, Guinet E. Nicotine alters the biological activities of developing mouse bone marrow-derived dendritic cells (DCs). Immunol Lett 2007;109:155-64.
22. Nouri-Shirazi M, Guinet E. Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology 2003;109:365-73.
23. Hogg N. Nicotine has suppressive effects on dendritic cell function. Immunology 2003;109:329-30.
24. Chang J, Renne R, Dittmer D, Ganem D. Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. Virology 2000;266:17-25.
25. Ford PW, Hamden KE, Whitman AG, et al. Cigarette smoke concentrate inhibits Kaposi's sarcoma-associated herpesvirus infection. Virus Res 2005;114:172-6.
26. Diamondstone LS, Tollerud DJ, Fuchs D, et al. Factors influencing serum neopterin and β 2-microglobulin levels in a healthy diverse population. J Clin Immunol 1994;14:368-74.
27. Tollerud DJ, Clark JW, Brown LM, et al. The effects of cigarette smoking on T cell subsets. A population-based survey of healthy caucasians. Am Rev Respir Disease 1989;139:1446-51.
28. Brown EE, Whitby D, Vitale F, et al. Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma. Cancer 2006;107:2282-90.
29. Louthrenoo W, Kasitanon N, Mahanuphab P, Bhoopat L, Thongprasert S. Kaposi's sarcoma in rheumatic diseases. Semin Arthritis Rheum 2003;32:326-33.
30. Cai J, Zheng T, Lotz M, Zhang Y, Masood R, Gill P. Glucocorticoids induce Kaposi's sarcoma cell proliferation through the regulation of transforming growth factor-β. Blood 1997;89:1491-500.
31. Kroumpouzos G, Delaney T, Phillips TJ. Combined classic and iatrogenic Kaposi's sarcoma. Corticosteroid withdrawal can result in remission. Postgrad Med 2000;108:103-6.
32. Leung F, Fam AG, Osoba D. Kaposi's sarcoma complicating corticosteroid therapy for temporal arteritis. Am J Med 1981;71:320-2.
33. Weissmann A, Linn S, Weltfriend S, Friedman-Birnbaum R. Epidemiological study of classic Kaposi's sarcoma: a retrospective review of 125 cases from Northern Israel. J Eur Acad Dermatol Venereol 2000;14:91-5.
34. Lanternier F, Lebbe C, Schartz N, et al. Kaposi's sarcoma in HIV-negative men having sex with men. AIDS 2008;22:1163-8.
35. Mazzaglia G, Yurgin N, Boye KS, et al. Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: a 4-year retrospective study from national primary care data. Pharmacological Research 2008;57:358-63.
36. Davis DA, Rinderknecht AS, Zoeteweij JP, et al. Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood 2001;97:3244-50.
37. Catrina S-B, Botusan IR, Rantanen A, et al. Hypoxia-inducible factor-1α and hypoxia-inducible factor-2α are expressed in Kaposi sarcoma and modulated by insulin-like growth factor-I. Clin Cancer Res 2006;12:4506-14.
38. Rose PP, Carroll JM, Carroll PA, et al. The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma. Oncogene 2007;26:1995-2005.
39. Sobngwi E, Choukem SP, Agbalika F, et al. Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in Sub-Saharan Africans. JAMA 2008;299:2770-6.
40. Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 1998;90:395-7.